Elucidating how genetic variation contributes to disease susceptibility and drug response requires human Induced Pluripotent Stem Cell (hIPSC) lines from many human patients. Yet, current methods of hIPSC generation are…
Alzheimer’s disease is the most common cause of dementia in the elderly, affecting over 5 million people in the US alone. Boosting immune responses to beta-Amyloid (Aβ) has proven beneficial…
Alzheimer’s disease is the most common cause of dementia in the elderly, affecting over 5 million people in the US alone. Boosting immune responses to beta-Amyloid (Aβ) has proven beneficial…
Alzheimer disease (AD), the most common cause of dementia among the elderly and the third leading cause of death, presently afflicts over 5 million people in the USA, including over…
By 25, Lauren Miller had already lost two grandparents to Alzheimer's and witnessed her mother's early onset at just 55 years old. Watch Lauren's recent talk about her family history…
In this first installment of CIRM TV's "Ask the Expert" video series, Larry Goldstein of the University of California, San Diego answers questions about finding stem cell based therapies for…
Bonus footage from the first installment of CIRM TV's "Ask the Expert" video series in which Larry Goldstein of the University of California, San Diego answers questions about finding stem…
Mathew Blurton-Jones speaks at the 2011 CIRM Grantee Meeting about promising research which uses neural stem cells to improve learning and memory in mice with alzheimer's like symptoms.
